vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and PATHWARD FINANCIAL, INC. (CASH). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $276.3M, roughly 1.0× PATHWARD FINANCIAL, INC.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 26.4%, a 69.9% gap on every dollar of revenue. Over the past eight quarters, PATHWARD FINANCIAL, INC.'s revenue compounded faster (21.0% CAGR vs 17.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.
ACAD vs CASH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $276.3M |
| Net Profit | $273.6M | $72.9M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | — |
| Net Margin | 96.3% | 26.4% |
| Revenue YoY | 9.4% | — |
| Net Profit YoY | 90.3% | — |
| EPS (diluted) | $1.61 | $3.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $276.3M | ||
| Q4 25 | $284.0M | $173.1M | ||
| Q3 25 | $278.6M | $186.7M | ||
| Q2 25 | $264.6M | $195.8M | ||
| Q1 25 | $244.3M | $274.8M | ||
| Q4 24 | $259.6M | $182.6M | ||
| Q3 24 | $250.4M | $179.5M | ||
| Q2 24 | $242.0M | $188.6M |
| Q1 26 | — | $72.9M | ||
| Q4 25 | $273.6M | $35.2M | ||
| Q3 25 | $71.8M | $38.8M | ||
| Q2 25 | $26.7M | $42.1M | ||
| Q1 25 | $19.0M | $75.0M | ||
| Q4 24 | $143.7M | $30.0M | ||
| Q3 24 | $32.8M | $33.5M | ||
| Q2 24 | $33.4M | $44.9M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 6.1% | 24.6% | ||
| Q3 25 | 12.8% | 25.9% | ||
| Q2 25 | 12.2% | 24.1% | ||
| Q1 25 | 7.9% | 33.2% | ||
| Q4 24 | 59.1% | 19.8% | ||
| Q3 24 | 12.6% | 20.9% | ||
| Q2 24 | 12.6% | 27.1% |
| Q1 26 | — | 26.4% | ||
| Q4 25 | 96.3% | 20.3% | ||
| Q3 25 | 25.8% | 20.8% | ||
| Q2 25 | 10.1% | 21.5% | ||
| Q1 25 | 7.8% | 27.3% | ||
| Q4 24 | 55.4% | 16.4% | ||
| Q3 24 | 13.1% | 18.7% | ||
| Q2 24 | 13.8% | 23.8% |
| Q1 26 | — | $3.35 | ||
| Q4 25 | $1.61 | $1.57 | ||
| Q3 25 | $0.42 | $1.69 | ||
| Q2 25 | $0.16 | $1.81 | ||
| Q1 25 | $0.11 | $3.14 | ||
| Q4 24 | $0.86 | $1.23 | ||
| Q3 24 | $0.20 | $1.34 | ||
| Q2 24 | $0.20 | $1.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $157.6M |
| Total DebtLower is stronger | — | $59.5M |
| Stockholders' EquityBook value | $1.2B | $850.7M |
| Total Assets | $1.6B | $7.1B |
| Debt / EquityLower = less leverage | — | 0.07× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $157.6M | ||
| Q4 25 | $177.7M | $331.2M | ||
| Q3 25 | $258.0M | $120.6M | ||
| Q2 25 | $253.6M | $258.3M | ||
| Q1 25 | $217.7M | $254.2M | ||
| Q4 24 | $319.6M | $597.4M | ||
| Q3 24 | $155.1M | $158.3M | ||
| Q2 24 | $177.1M | $298.9M |
| Q1 26 | — | $59.5M | ||
| Q4 25 | — | $33.5M | ||
| Q3 25 | — | $33.5M | ||
| Q2 25 | — | $33.4M | ||
| Q1 25 | — | $33.4M | ||
| Q4 24 | — | $33.4M | ||
| Q3 24 | — | $33.4M | ||
| Q2 24 | — | $33.3M |
| Q1 26 | — | $850.7M | ||
| Q4 25 | $1.2B | $854.5M | ||
| Q3 25 | $917.3M | $858.0M | ||
| Q2 25 | $822.4M | $819.0M | ||
| Q1 25 | $765.2M | $814.7M | ||
| Q4 24 | $732.8M | $758.3M | ||
| Q3 24 | $577.2M | $822.5M | ||
| Q2 24 | $516.7M | $748.4M |
| Q1 26 | — | $7.1B | ||
| Q4 25 | $1.6B | $7.6B | ||
| Q3 25 | $1.3B | $7.2B | ||
| Q2 25 | $1.2B | $7.2B | ||
| Q1 25 | $1.1B | $7.0B | ||
| Q4 24 | $1.2B | $7.6B | ||
| Q3 24 | $976.9M | $7.5B | ||
| Q2 24 | $914.1M | $7.5B |
| Q1 26 | — | 0.07× | ||
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.04× | ||
| Q1 25 | — | 0.04× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-48.7M | $108.3M | ||
| Q3 25 | $74.3M | $303.7M | ||
| Q2 25 | $64.0M | $30.4M | ||
| Q1 25 | $20.3M | $188.3M | ||
| Q4 24 | $40.4M | $-71.7M | ||
| Q3 24 | $63.2M | $143.1M | ||
| Q2 24 | $25.0M | $113.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | $104.1M | ||
| Q3 25 | $73.9M | $300.3M | ||
| Q2 25 | — | $27.7M | ||
| Q1 25 | — | $184.7M | ||
| Q4 24 | — | $-73.8M | ||
| Q3 24 | $63.2M | $138.8M | ||
| Q2 24 | — | $111.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 60.1% | ||
| Q3 25 | 26.5% | 160.9% | ||
| Q2 25 | — | 14.1% | ||
| Q1 25 | — | 67.2% | ||
| Q4 24 | — | -40.4% | ||
| Q3 24 | 25.2% | 77.3% | ||
| Q2 24 | — | 58.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | 0.1% | 1.8% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | 0.0% | 2.4% | ||
| Q2 24 | — | 1.2% |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | 3.08× | ||
| Q3 25 | 1.03× | 7.83× | ||
| Q2 25 | 2.40× | 0.72× | ||
| Q1 25 | 1.07× | 2.51× | ||
| Q4 24 | 0.28× | -2.39× | ||
| Q3 24 | 1.93× | 4.27× | ||
| Q2 24 | 0.75× | 2.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
CASH
| Noninterest Income | $151.2M | 55% |
| Net Interest Income | $125.1M | 45% |
